Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,137 public trials 1,865 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, not recruiting

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

NCT03870464

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +21 more
Locations: Department of Oncology, Odense University Hospital Odense, Denmark

View Trial Details

Active, not recruiting

JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

NCT06391944

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Li Zhang Beijing, Beijing Municipality, China

View Trial Details

Active, not recruiting

Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy

NCT05383716

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Active, not recruiting

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

NCT05931445

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +51 more
Locations: Kobe University Graduate School Kobe, Hyōgo, Japan

View Trial Details

Active, not recruiting

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

NCT02991924

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: National Cancer Center (NCC) Korea Goyang-si, Gyeonggi-do, South Korea

View Trial Details

Active, not recruiting

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

NCT05636592

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: The Fourth Affiliated Hospital of Zhejiang University Yiwu, Zhejiang, China

View Trial Details

Active, not recruiting

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

NCT05219734

Conditions: Bladder Cancer, Bronchial Neoplasms, Cancer, +34 more
Locations: Columbus Regional Health Columbus, Indiana, United States

Onslow Radiation Jacksonville, North Carolina, United States

View Trial Details

Active, not recruiting

Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study

NCT02247453

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Active, not recruiting

Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

NCT04392505

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +12 more
Locations: North Estonia Medical Centre Tallinn, Estonia

Oulu University Hospital Oulu, Finland

Tampere University Hospital Tampere, Finland

Turku University Hospital Turku, Finland

View Trial Details

Active, not recruiting

Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma

NCT04300244

Conditions: Adenoma, Cancer, Cancer of Lung, +17 more
Locations: University of Western Australia Perth, Australia

Aalborg University Hospital Aalborg, Denmark

Copenhagen University Hospital Copenhagen, Denmark

Oslo University Hospital Oslo, Norway

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions